Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress ...
Around 3 million people worldwide struggle with chronic pancreatitis, a condition in which the pancreas becomes inflamed, ...
The Sacramento Zoo is mourning the death of Makan, its male Sumatran orangutan. Zoo officials said Makan died Monday after ...
Patients with cystic fibrosis often reduce or discontinue respiratory cotherapies after starting CFTR modulators without affecting clinical status.
A generic formulation of elexacaftor-tezacaftor-ivacaftor shows real-world benefits and appears safe in children and ...
Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Even after the introduction of ETI for cystic fibrosis, habit continues to have a key role in adherence to inhaled medicines in patients with CF.
A recent study published in Current Molecular Pharmacology demonstrates that puerarin-a bioactive isoflavone derived from ...
The FDA’s approval of inebilizumab has heralded a new era for patients with IgG4-related disease, while novel agents moving ...
Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results